Neofect Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Neofect has been growing earnings at an average annual rate of 26.6%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 15.9% per year.
Belangrijke informatie
26.6%
Groei van de winst
39.6%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 22.7% |
| Inkomstengroei | 15.9% |
| Rendement op eigen vermogen | -4.6% |
| Nettomarge | -5.5% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Neofect geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 23,112 | -1,274 | 8,150 | 1,621 |
| 31 Mar 24 | 24,918 | -4,863 | 6,885 | 1,465 |
| 31 Dec 23 | 26,614 | -4,963 | 7,287 | 1,546 |
| 30 Sep 23 | 28,269 | -5,356 | 8,817 | 1,744 |
| 30 Jun 23 | 26,529 | -7,692 | 9,143 | 1,874 |
| 31 Mar 23 | 25,967 | -9,137 | 11,290 | 1,995 |
| 31 Dec 22 | 26,202 | -9,621 | 11,737 | 1,945 |
| 30 Sep 22 | 25,557 | -3,996 | 11,209 | 1,559 |
| 30 Jun 22 | 25,550 | -3,204 | 10,836 | 1,434 |
| 31 Mar 22 | 24,421 | -4,844 | 11,368 | 1,478 |
| 31 Dec 21 | 23,158 | -5,045 | 10,994 | 1,500 |
| 30 Sep 21 | 20,340 | -9,269 | 12,202 | 1,726 |
| 30 Jun 21 | 19,696 | -11,466 | 12,883 | 1,912 |
| 31 Mar 21 | 19,064 | -13,398 | 12,614 | 1,848 |
| 31 Dec 20 | 18,625 | -15,007 | 13,993 | 1,654 |
| 30 Sep 20 | 17,726 | -20,617 | 14,419 | 1,608 |
| 30 Jun 20 | 18,477 | -20,348 | 15,447 | 1,344 |
| 31 Mar 20 | 15,551 | -17,963 | 15,839 | 1,242 |
| 31 Dec 19 | 12,311 | -15,845 | 14,481 | 1,240 |
| 30 Sep 19 | 11,099 | -9,704 | 12,781 | 968 |
| 30 Jun 19 | 7,071 | -8,088 | 10,917 | 976 |
| 31 Mar 19 | 6,583 | -9,517 | 8,579 | 802 |
| 31 Dec 18 | 5,653 | -9,634 | 7,844 | 916 |
| 30 Sep 18 | 4,527 | -9,181 | 6,593 | 1,024 |
| 30 Jun 18 | 4,882 | -8,276 | 5,807 | 1,172 |
| 31 Mar 18 | 4,234 | -5,190 | 5,738 | 1,430 |
| 31 Dec 17 | 4,454 | -4,389 | 5,132 | 1,328 |
| 31 Dec 16 | 1,980 | -5,920 | 3,540 | 589 |
Kwaliteitswinsten: A290660 is currently unprofitable.
Groeiende winstmarge: A290660 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: A290660 is unprofitable, but has reduced losses over the past 5 years at a rate of 26.6% per year.
Versnelling van de groei: Unable to compare A290660's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: A290660 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4%).
Rendement op eigen vermogen
Hoge ROE: A290660 has a negative Return on Equity (-4.62%), as it is currently unprofitable.